REGN

Regeneron Pharmaceuticals Inc
$614.78 -1.08%

Recent alerts on REGN

All signals →
News Chip stocks lead Nasdaq's gainers this week; Intuit plunges most after Q3 print
10d ago
News Regeneron backed Parabilis Medicines seeks U.S. IPO
12d ago
News This $24 Million Buy Amid a 45% Stock Drop Signals Conviction in a High-Margin Data Business
14d ago
News Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition
14d ago
News Is Regeneron a Multimillionaire-Maker Stock?
14d ago
News AstraZeneca Strengthens Position In COPD Race With Successful Trials
14d ago
News Biotech Sector May Flip to Market Leader by Year-End
14d ago
News FDA Delays Key Sanofi Multiple Sclerosis Drug Decision
14d ago
News Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
14d ago
News Regeneron (REGN) Q2 EPS Jumps 53%
14d ago
News The Company Buying 23andMe Is a Pharmaceutical Giant. Here's How Investors Can Benefit From the Move.
14d ago
News Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data
14d ago
News Temu Parent PDD, Regeneron Pharmaceutical And Burlington Stores Are Among Top 11 Large-Cap Losers Last Week (May 26-May 30): Are The Others In Your Portfolio?
14d ago
News FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder
14d ago
News Does the 23andMe Acquisition Make Regeneron a Buy Now?
14d ago
News Sanofi Asthma Drug Misses Primary Goal, Plans For Pivotal Study
14d ago
News FDA Sets The Countdown: Regeneron's Eylea HD Could Be Headed For Major Expansion
14d ago
News Market Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and Hold
14d ago
News Amgen And Kyowa Kirin's Rocatinlimab Reduces Eczema Severity In Phase 3 Study
14d ago
News This Company Just Initiated a Quarterly Dividend: Time to Buy?
14d ago
News Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
14d ago
News Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
14d ago
News Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
14d ago
News FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
14d ago
News This Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street
14d ago

Get push alerts for REGN

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS